Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,678 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study.
Li RK, Tokunaga E, Adamchuk H, Vladimirov V, Yanez E, Lee KS, Bondarenko I, Vana A, Hilton F, Ishikawa T, Tajima K, Lipatov O. Li RK, et al. Among authors: tajima k. BioDrugs. 2022 Jan;36(1):55-69. doi: 10.1007/s40259-021-00513-7. Epub 2022 Feb 8. BioDrugs. 2022. PMID: 35133617 Free PMC article. Clinical Trial.
A descriptive analysis of real-world oncology biosimilar use in Japan.
Roth JA, Rahshenas M, Nowacki G, Masurkar N, Shelbaya A, Tajima K, Dorman S, Ono C. Roth JA, et al. Among authors: tajima k. Future Oncol. 2024;20(25):1837-1850. doi: 10.1080/14796694.2024.2352405. Epub 2024 Jun 12. Future Oncol. 2024. PMID: 38864611 Free PMC article.
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.
Yoshinami T, Nagai SE, Hattori M, Okamura T, Watanabe K, Nakayama T, Masuda H, Tsuneizumi M, Takabatake D, Harao M, Yoshino H, Mori N, Yasojima H, Oshiro C, Iwase M, Yamaguchi M, Sangai T, Kosaka N, Tajima K, Masuda N. Yoshinami T, et al. Among authors: tajima k. Breast Cancer. 2024 Jul;31(4):621-632. doi: 10.1007/s12282-024-01575-5. Epub 2024 Apr 20. Breast Cancer. 2024. PMID: 38642245 Free PMC article.
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.
Funayama E, Hosonuma M, Tajima K, Isobe J, Baba Y, Murayama M, Narikawa Y, Toyoda H, Tsurui T, Maruyama Y, Sasaki A, Amari Y, Yamazaki Y, Nakashima R, Uchiyama J, Nakano R, Shida M, Sasaki A, Udaka Y, Oguchi T, Sambe T, Kobayashi S, Tsuji M, Kiuchi Y, Kim YG, Wada S, Tsunoda T, Akiyama M, Nobe K, Kuramasu A, Yoshimura K. Funayama E, et al. Among authors: tajima k. Biomed Pharmacother. 2025 Jan;182:117749. doi: 10.1016/j.biopha.2024.117749. Epub 2024 Dec 23. Biomed Pharmacother. 2025. PMID: 39719740 Free article.
Steering perovskite precursor solutions for multijunction photovoltaics.
Hu S, Wang J, Zhao P, Pascual J, Wang J, Rombach F, Dasgupta A, Liu W, Truong MA, Zhu H, Kober-Czerny M, Drysdale JN, Smith JA, Yuan Z, Aalbers GJW, Schipper NRM, Yao J, Nakano K, Turren-Cruz SH, Dallmann A, Christoforo MG, Ball JM, McMeekin DP, Zaininger KA, Liu Z, Noel NK, Tajima K, Chen W, Ehara M, Janssen RAJ, Wakamiya A, Snaith HJ. Hu S, et al. Among authors: tajima k. Nature. 2024 Dec 23. doi: 10.1038/s41586-024-08546-y. Online ahead of print. Nature. 2024. PMID: 39715627
1,678 results